Stemline Therapeutics Announces that CMS Grants New Technology Add-on Payment (NTAP) to ELZONRIS®

NEXT STORY
Global Veterinary Infectious Disease Diagnostics Market to Reach $2.2 Billion by 2024 – Emerging Countries Present Lucrative Opportunities
PREV STORY
R1 RCM Reports Second Quarter 2019 Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Medication Adherence Market to Reach $3.6 Billion by 2023: P&S Market Research

NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Medication adherence market is forecasted to reach ...

author_avatar
NASDAQ Market News

TRIO Announces Participation in the Avoca Diligent™ Prequalification Platform

EDMONTON, Alberta, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO) is ...

author_avatar
NASDAQ Market News

Epizyme Announces Tazemetostat to be Evaluated in NCI’s Recently Initiated NCI-COG Pediatric MATCH Trial

CAMBRIDGE, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News